These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22596351)
1. Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators. Burger PB; Yuan H; Karakas E; Geballe M; Furukawa H; Liotta DC; Snyder JP; Traynelis SF Mol Pharmacol; 2012 Aug; 82(2):344-59. PubMed ID: 22596351 [TBL] [Abstract][Full Text] [Related]
2. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold. Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308 [TBL] [Abstract][Full Text] [Related]
3. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists. Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815 [TBL] [Abstract][Full Text] [Related]
4. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Karakas E; Simorowski N; Furukawa H Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647 [TBL] [Abstract][Full Text] [Related]
5. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling. Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987 [TBL] [Abstract][Full Text] [Related]
6. The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor. Kaiser TM; Kell SA; Kusumoto H; Shaulsky G; Bhattacharya S; Epplin MP; Strong KL; Miller EJ; Cox BD; Menaldino DS; Liotta DC; Traynelis SF; Burger PB Mol Pharmacol; 2018 Feb; 93(2):141-156. PubMed ID: 29242355 [No Abstract] [Full Text] [Related]
7. Allosteric regulation in NMDA receptors revealed by the genetically encoded photo-cross-linkers. Tian M; Ye S Sci Rep; 2016 Oct; 6():34751. PubMed ID: 27713495 [TBL] [Abstract][Full Text] [Related]
8. On mechanism of allosteric modulation of NMDA receptor via amino-terminal domains. Karlov DS; Radchenko EV; Zefirov AN; Palyulin VA; Pentkovski VM; Zefirov NS Biochem Biophys Res Commun; 2012 Aug; 424(4):687-90. PubMed ID: 22789854 [TBL] [Abstract][Full Text] [Related]
9. Structural changes of regulatory domain heterodimer of N-methyl-D-aspartate receptor subunits GluN1 and GluN2B through the binding of spermine and ifenprodil. Tomitori H; Suganami A; Saiki R; Mizuno S; Yoshizawa Y; Masuko T; Tamura Y; Nishimura K; Toida T; Williams K; Kashiwagi K; Igarashi K J Pharmacol Exp Ther; 2012 Oct; 343(1):82-90. PubMed ID: 22743575 [TBL] [Abstract][Full Text] [Related]
10. Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds. Temme L; Bechthold E; Schreiber JA; Gawaskar S; Schepmann D; Robaa D; Sippl W; Seebohm G; Wünsch B Eur J Med Chem; 2020 Mar; 190():112138. PubMed ID: 32070917 [TBL] [Abstract][Full Text] [Related]